Direct-to-Consumer Pharmaceutical Advertising Therapeutic or Toxic?

P and T

Volumn 36, Issue 10, 2011, Pages 669-684

  Lee Ventola, C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIRECT TO CONSUMER PHARMACEUTICAL ADVERTIZING; DRUG INDUSTRY; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; INTERNET; MASS MEDIUM; NEW ZEALAND; PRODUCT SAFETY; UNITED STATES;

EID: 80655148818     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kuehn BM. FDA weighs limits for online ads. JAMA 2010;303(4): 311-313.
2. Greene JA, Herzberg D. Hidden in plain sight: Marketing prescription drugs to consumers in the twentieth century. Am J Public Health 2010;100(5):793-803.
3. DTC marketing mix: Radio and outdoor ad spending soars, Internet not so much. Pharma Marketing. Available at: http://pharmamkting.blogspot.com/2010/06/dtc-marketing-mix-radiooutdoor-ad.html. Accessed July 28, 2011.
4. Abel GA, Penson RT, Joffe S, et al. Direct-to-consumer advertising in oncology. Oncologist 2006;11(2):217-226.
5. Connors AL. Big bad pharma: An ethical analysis of physiciandirected and consumer-directed marketing tactics. Albany Law Rev 2009;73(1):243-282.
6. Donahue JM, Cervasco M, Rosenthal MB. A decade of direct-toconsumer advertising of prescription drugs. N Engl J Med 2007; 357(7):673-681.
7. Almasi EA, Stafford RS, Kravitz RL, Mansfield PR. What are the public health effects of direct-to-consumer advertising? PLoS Med 2006;3(3):e145.
8. Morris AW, Gadson SL, Burroughs V. For the good of the patient: Survey of the physicians of the National Medical Association regarding perceptions of DTC advertising, Part II, 2006. J Natl Med Assoc 2007;99(3):287-293.
9. Schuchman M. Drug risks and free speech: Can Congress ban consumer drug ads? N Engl J Med 2007;356(22):2236-2239.
10. Silversides A. Abramson: Direct-to-consumer advertising will erode health care. Can Med Assoc J 2008;178(9):1126-1127.
11. Morgan SG. Direct-to-consumer advertising and expenditures on prescription drugs: A comparison of experiences in the United States and Canada. Open Med 2007;1(1):e37-e45.
12. Nelson R. When ads trump evidence: Is direct-to-consumer advertising leading practice? Am J Nurs 2007;107(10):25-26.
13. Humphreys G. Direct-to-consumer advertising under fire. Bull World Health 2009;87:576-577.
14. FDA. Basics of drug ads. Available at: www.fda.gov/Drugs/ResourcesForYou/Consumers/PrescriptionDrugAdvertising/ucm072077.htm. Accessed July 28, 2011.
15. Liang BA, Mackey T. Direct-to-consumer advertising with interactive Internet media: Global regulation and public health issues. JAMA 2011;305(8):824-825.
16. Greene JA, Kesselheim AS. Pharmaceutical marketing and the new social media. N Engl J Med 2010;363(22):2087-2089.
17. Boden WE, Diamond GA. DTCA for PTCA: Crossing the line in consumer health education? N Engl J Med 2008;358(21):2197-2200.
18. Frosch DL, Grande D, Tarn DM, Kravitz RL. A decade of controversy: Balancing policy with evidence in the regulation of prescription drug advertising. Am J Public Health 2010;100(1):24-32.
19. Delbaere M, Smith MC. Health care knowledge and consumer learning: The case of direct-to-consumer advertising. Health Mark Q 2006;23(3):9-29.
20. Shaw A. Direct-to-consumer advertising of pharmaceuticals: DTC regulation. ProQuest, March 2008. Available at: www.csa.com/discoveryguides/direct/review3.php. Accessed July 28, 2011.
21. Lee AL. Changing effects of direct-to-consumer broadcast drug information advertising sources on prescription drug requests. Health Commun 2009;24:361-376.
22. Gebhart F. DTC ad spending decreased last year. Modern Med, April 27, 2009. Available at: www.commercialalert.org/issues/health/drug-marketing/dtc-ad-spending-decreased-last-year. Accessed September 15, 2011.
23. Direct-to-consumer advertising in the United States (last modified May 14, 2008). Sourcewatch. Available at: www.sourcewatch.org/index.php?title=Direct-to-consumer_advertising_in_the_United_States. Accessed July 28, 2011.
24. Parnes B, Smith PC, Gilroy C, et al. Lack of impact of direct-toconsumer advertising on the physician-patient encounter in primary care: A SNOCAP report. Ann Fam Med 2009;7(1):41-46.
25. Shaw A. Direct-to-consumer advertising of pharmaceuticals: The DTC advertising debate. ProQuest, March 2008. Available at: www.csa.com/discoveryguides/direct/review4.php. Accessed July 28, 2011.
26. Shaw A. Direct-to-consumer advertising of pharmaceuticals: Trends in DTC advertising spending. ProQuest, March 2008. Available at: www.csa.com/discoveryguides/direct/review2.php.Accessed July 28, 2011.
27. Frosch DL. Creating demand for prescription drugs: A content analysis of television direct-to-consumer advertising. Ann Fam Med 2007;5(1):6-13.
28. Wadman M. Drug ads move online, creating a web of regulatory challenges. Nat Med 2010;16(1):22.
29. Kellerman R. AAFP supports improvements, not ban, on directto-consumer prescription drug ads. Ann Fam Med 2007;5(2):180-181.
30. Nadler pushes to end tax breaks for pharmaceutical companies. February 15, 2011. Available at: http://nadler.house.gov/ index.php?option=com_content&task=blogsection&id=11&Itemid=46&limit=10&limitstart=70. Accessed July 28, 2011.
31. Auton F. Opinion: The case for advertising pharmaceuticals directto-consumers. Future Med Chem 2009;1(4):587-592.
32. Aikin KJ, Swasy JL, Braman AC. Patient and Physician Attitudes and Behaviors Associated With DTC Promotion of Prescription Drugs-Summary of FDA Survey Research Results. Washington, D.C.: U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research; November 2004.
33. General Accountability Office. Improvements needed in FDA's oversight of direct-to-consumer advertising. November 2006. Available at: www.gao.gov/new.items/d0754.pdf. Accessed July 28, 2011.
34. Mintzes B, Mangin D. Direct-to-consumer advertising of prescription medicines: A counter argument. Future Med Chem 2009; 1(9):1555-1560.
35. Lee AL. Who are the opinion leaders? The physicians, pharmacists, patients and direct-to-consumer advertising. J Health Commun 2010;15(6):629-655.
36. Law MR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Arch Intern Med 2009;169(21): 1969-1974.
37. Davis J. The effect of qualifying language on perceptions of drug appeal, drug experience, and estimates of side-effect incidence in DTC advertising. J Health Commun 2007;12(7):607-622.
38. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. JAMA 2005;293(16):1995-2002.
39. Stange KC. Time to ban direct-to-consumer prescription drug marketing. Ann Fam Med 2007;5(2):101-104.